Currently, she is using neuroimaging, fluid biomarkers and neuropsychological testing to define between different subtypes of disease, with an ultimate aim to improve treatments. Maryna is also interested in Personalized solutions that predict treatment efficiency in depression and progression of neurodegenerative diseases. Beside this she is currently teaching introduction to medicine with a focus on digital health in HTW Berlin and giving lectures on basics of nervous activity, depression and schizophrenia at the University of Leipzig and Max Planck.
